Cargando…

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection

BACKGROUND: In this study, we further investigated the association of two biomarkers, CCL18 and A1AT, with bladder cancer (BCa) and evaluated the influence of potentially confounding factors in an experimental model. METHODS: In a cohort of 308 subjects (102 with BCa), urinary concentrations of CCL1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyake, Makito, Ross, Shanti, Lawton, Adrienne, Chang, Myron, Dai, Yunfeng, Mengual, Lourdes, Alcaraz, Antonio, Giacoia, Evan Gomes, Goodison, Steve, Rosser, Charles J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846766/ https://www.ncbi.nlm.nih.gov/pubmed/24011266 http://dx.doi.org/10.1186/1471-2490-13-42

Ejemplares similares

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer
por: Miyake, Makito, et al.
Publicado: (2014)

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
por: Miyake, Makito, et al.
Publicado: (2013)

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
por: Zhang, Ge, et al.
Publicado: (2014)

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
por: Miyake, Makito, et al.
Publicado: (2013)

Influencing factors on the NMP-22 urine assay: an experimental model
por: Miyake, Makito, et al.
Publicado: (2012)

CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

Simultaneous multi-analyte urinary protein assay for bladder cancer detection
por: Rosser, Charles J, et al.
Publicado: (2014)

Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors
por: Zhang, Ge, et al.
Publicado: (2014)

IL-8 as a urinary biomarker for the detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2012)

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort
por: Goodison, Steve, et al.
Publicado: (2016)

Urinary mRNA biomarker panel for the detection of urothelial carcinoma
por: Urquidi, Virginia, et al.
Publicado: (2016)

A microRNA biomarker panel for the non-invasive detection of bladder cancer
por: Urquidi, Virginia, et al.
Publicado: (2016)

Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
por: Gomes-Giacoia, Evan, et al.
Publicado: (2014)

A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
por: Goodison, Steve, et al.
Publicado: (2012)

Locally advanced paraganglioma of the urinary bladder: a case report
por: Beilan, Jonathan, et al.
Publicado: (2013)

Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature
por: Beilan, Jonathan A, et al.
Publicado: (2013)

Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
por: Goodison, Steve, et al.
Publicado: (2013)

A multiplex immunoassay for the non-invasive detection of bladder cancer
por: Shimizu, Yoshiko, et al.
Publicado: (2016)

Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer
por: Ingelmo-Torres, Mercedes, et al.
Publicado: (2017)

Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
por: Hirasawa, Yosuke, et al.
Publicado: (2021)

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
por: Miyake, Makito, et al.
Publicado: (2019)

Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer
por: Murakami, Kaoru, et al.
Publicado: (2023)

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer
por: Masuda, Norihiko, et al.
Publicado: (2018)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy
por: Miyake, Makito, et al.
Publicado: (2018)

Prognostic value of circulating microRNAs in upper tract urinary carcinoma
por: Montalbo, Ruth, et al.
Publicado: (2018)

CCL18 in the Progression of Cancer
por: Korbecki, Jan, et al.
Publicado: (2020)

CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells
por: Liu, Xiaoqiang, et al.
Publicado: (2019)

Posterior Layering of Fluorine-18 Fluorodeoxyglucose in the Urinary Bladder
por: Khoo, Alex Cheen Hoe
Publicado: (2018)

Diagnostic and prognostic role of urinary collagens in primary human bladder cancer
por: Miyake, Makito, et al.
Publicado: (2017)

Validation of Urine-based Gene Classifiers for Detecting Bladder Cancer in a Chinese Study
por: Han, Chengtao, et al.
Publicado: (2018)

Differential Dermal Expression of CCL17 and CCL18 in Tuberculoid and Lepromatous Leprosy
por: Berrington, William R., et al.
Publicado: (2014)

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
por: Urbanek, Cydney, et al.
Publicado: (2011)

Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
por: Carrasco, Raquel, et al.
Publicado: (2022)

Radiosensitization in prostate cancer: mechanisms and targets
por: Palacios, Diego A, et al.
Publicado: (2013)

Corrigendum to “CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer” [Neoplasia 18 (2016) 636–646]
por: Miyake, Makito, et al.
Publicado: (2017)

Unusual location of a urinary bladder cancer metastasis
por: Forte, Serafino, et al.
Publicado: (2015)

Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer
por: Maesaka, Fumisato, et al.
Publicado: (2022)

Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis—Part B
por: Caliskan, Canay, et al.
Publicado: (2020)

Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis: Part A
por: Wiertz, Ivo A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pgjog9a3p2pjcegkd3v4u7c63f